Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale

MONTEJO, Angel L, DEAKIN, JFW, GAILLARD, Raphael, HARMER, Catherine, MEYNIEL, Florent, JABOURIAN, Artin, GABRIEL, Cecilia, GRUGET, Celine, KLINGE, Corinna, MACFAYDEN, Christine, MILLIGAN, Holly, MULLINGS, Emma and GOODWIN, Guy (2015). Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. Journal of Psychopharmacology, 29 (10), 1119-1128.

[img]
Preview
PDF
Mullings_Better_Sexual_Acceptability.pdf

Download (325kB) | Preview
Official URL: https://journals.sagepub.com/doi/10.1177/026988111...
Link to published version:: https://doi.org/10.1177/0269881115599385

Abstract

The present double-blind, placebo-controlled study evaluates the effects of agomelatine and the selective serotonin reuptake inhibitor escitalopram on sexual dysfunction in healthy men and women.

Item Type: Article
Uncontrolled Keywords: 11 Medical And Health Sciences; 17 Psychology And Cognitive Sciences; Psychiatry
Identification Number: https://doi.org/10.1177/0269881115599385
Page Range: 1119-1128
SWORD Depositor: Symplectic Elements
Depositing User: Symplectic Elements
Date Deposited: 21 Jan 2019 10:07
Last Modified: 18 Mar 2021 02:37
URI: https://shura.shu.ac.uk/id/eprint/23496

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics